COMPOSITION
Each ml contains:
Etamsylate BP 125mg
Water for Injection BP q.s.
CLINICAL PHARMACOLOGY
Pharmacodynamic properties
Pharmacotherapeutic group: Other systemic haemostatics.
ATC code: B02B X01
Etamsylate is a non-hormonal agent which reduces capillary exudation and blood loss.
Etamsylate does not affect the normal coagulation mechanism since administration is without
effect on prothrombin times, fibrinolysis, platelet count or function. Etamsylate is thought to act
by increasing capillary vascular wall resistance and platelet adhesiveness; in the presence of a
vascular lesion, it inhibits the biosynthesis and action of those prostaglandins which cause
platelet disaggregation, vasodilation and increased capillary permeability. Etamsylate does not
have a vasoconstricting action
Etamsylate Injection 125mgml